Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals

Diabetes

Volumn 63, Issue 8, 2014, Pages 2812-2820

  Daniele, Giuseppe ^a   Eldor, Roy ^a   Merovci, Aurora ^a   Clarke, Geoffrey D ^a   Xiong, Juan ^a   Tripathy, Devjit ^a   Taranova, Anna ^a   Abdul Ghani, Muhammad ^a   DeFronzo, Ralph A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; MITOCHONDRIA; OBESITY; PYRAZINES; REACTIVE OXYGEN SPECIES;

EID: 84904959809     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1130     Document Type: Article

References (30)

1. DeFronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009; 58: 773-795
2. Abdul-Ghani M.A., DeFronzo RA Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010; 2010:476279
3. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51:7-18
4. 1H NMR spectroscopy study. Diabetologia 1999; 42:113-116
5. Pan DA, Lillioja S, Kriketos A.D., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997; 46:983-988
6. Jacob S, Machann J, Rett K., et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999; 48:1113-1119
7. Petersen KF, Dufour S, Befroy D., Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350:664-671
8. Abdul-Ghani M.A., Jani R, Chavez A., Molina M, Tripathy D, DeFrozo RA Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic subjects. Diabetologia 2009; 52:574-582
9. Kelley DE, He J, Menshikova E.V., Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51:2944-2950
10. Holloszy JO. "Deficiency" of mitochondria in muscle does not cause insulin resistance. Diabetes 2013; 62:1036-1040
11. Hoeks J, Schrauwen P. Muscle mitochondria and insulin resistance: a human perspective. Trends Endocrinol Metab 2012; 23:444-450
12. Pagel-Langenickel I., Bao J, Pang L., Sack MN. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev 2010; 31: 25-51
13. Bajaj M, Suraamornkul S, Kashyap S., Cusi K, Mandarino L, DeFronzo RA Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab 2004; 89:4649-4655
14. Santomauro AT, Boden G, Silva M.E., et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999; 48:1836-1841
15. Bajaj M, Suraamornkul S, Romanelli A., et al. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005; 54:3148-3153
16. Abdul-Ghani M.A., Muller FL, Liu Y, et al Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endocrinol Metab 2008; 295:E678-E685
17. Stefan D, Di Cesare F, Andrasescu A, et al Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Meas Sci Technol 2009; 20:104035
18. Vanhamme L, van den Boogaart A, Van Huffel S; van den Boogaart A; Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129:35-43
19. Weis J, Johansson L, Ortiz-Nieto F, Ahlström H. Assessment of lipids in skeletal muscle by LCModel and AMARES. J Magn Reson Imaging 2009; 30: 1124-1129
20. Krssák M., Mlynárik V, Meyerspeer M., Moser E, Roden M. 1H NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA 2004; 16:155-159
21. Szczepaniak LS, Babcock EE, Schick F, et al Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276: E977-E989
22. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959; 82:420-430
23. Belfort R, Mandarino L, Kashyap S., et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005; 54:1640-1648
24. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46:3-10
25. DeFronzo RA, Ferrannini E, Simonson DC Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38:387-395
26. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37:667-687
27. Asmann YW, Stump CS, Short K.R., et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006; 55:3309-3319
28. Chavez AO, Kamath S, Jani R., et al. Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals. J Clin Endocrinol Metab 2010; 95:422-429
29. Brehm A, Krssak M, Schmid A.I., Nowotny P., Waldhäusl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006; 55:136-140
30. Hoeks J, van Herpen NA, Mensink M, et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010; 59:2117-2125